Cargando…

In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression

Introduction According to the 2014 Endocrine Society Clinical Practice Guideline on acromegaly, the confirmation of acromegaly diagnosis is established by finding a lack of suppression of growth hormone (GH) to < 1 ug/L following documented hyperglycemia during an oral glucose tolerance test. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugalho, Maria João, Lopes-Pinto, Mariana, Lemos, Carlos, Nobre, Ema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980919/
https://www.ncbi.nlm.nih.gov/pubmed/36874742
http://dx.doi.org/10.7759/cureus.34463
_version_ 1784899995276673024
author Bugalho, Maria João
Lopes-Pinto, Mariana
Lemos, Carlos
Nobre, Ema
author_facet Bugalho, Maria João
Lopes-Pinto, Mariana
Lemos, Carlos
Nobre, Ema
author_sort Bugalho, Maria João
collection PubMed
description Introduction According to the 2014 Endocrine Society Clinical Practice Guideline on acromegaly, the confirmation of acromegaly diagnosis is established by finding a lack of suppression of growth hormone (GH) to < 1 ug/L following documented hyperglycemia during an oral glucose tolerance test. However, in this setting, the concept of hyperglycemia has never been clearly defined. Objective This study aimed to define the hyperglycemic threshold required to induce GH suppression. Methods We retrieved the glycemia profile of 44 individuals after a standard 2-h 75g oral glucose tolerance test prescribed to assess GH suppression and performed a comprehensive analysis of two subgroups of individuals (28 reaching GH suppression and 16 in whom GH suppression was not observed). All of the data were analyzed with the program Graph Pad Prism. Differences between means were assessed by Student’s unpaired t-test or Mann-Whitney U test as deemed appropriate. Fisher’s exact test was used for categorical variables. Results Individuals in G1 and G2 were different only for the median basal GH and median IGF-1. No significant differences in terms of the prevalence of diabetes and prediabetes were found. The glucose peak was achieved earlier in the group that reached GH suppression. The median of the highest glucose values of both subgroups was not different. A correlation between peak and baseline glucose value was found only among those in whom GH suppression was reached. Among these, the median glucose peak (P50) was 177 mg/dl, whereas the 75(th) percentile (P75) and 25(th) percentile (P25) were 199 mg/dl and 120 mg/dl, respectively. Conclusion Considering that 75% of those in whom GH suppression was observed after an oral glucose overload test reached blood glucose values above 120 mg/dl, we propose to use this value as the blood glucose threshold for inducing GH suppression. In light of our results, whenever GH suppression is not observed; and the highest glycemic value is below 120 mg/dl, it might be useful to repeat the test prior to any conclusion.
format Online
Article
Text
id pubmed-9980919
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99809192023-03-03 In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression Bugalho, Maria João Lopes-Pinto, Mariana Lemos, Carlos Nobre, Ema Cureus Endocrinology/Diabetes/Metabolism Introduction According to the 2014 Endocrine Society Clinical Practice Guideline on acromegaly, the confirmation of acromegaly diagnosis is established by finding a lack of suppression of growth hormone (GH) to < 1 ug/L following documented hyperglycemia during an oral glucose tolerance test. However, in this setting, the concept of hyperglycemia has never been clearly defined. Objective This study aimed to define the hyperglycemic threshold required to induce GH suppression. Methods We retrieved the glycemia profile of 44 individuals after a standard 2-h 75g oral glucose tolerance test prescribed to assess GH suppression and performed a comprehensive analysis of two subgroups of individuals (28 reaching GH suppression and 16 in whom GH suppression was not observed). All of the data were analyzed with the program Graph Pad Prism. Differences between means were assessed by Student’s unpaired t-test or Mann-Whitney U test as deemed appropriate. Fisher’s exact test was used for categorical variables. Results Individuals in G1 and G2 were different only for the median basal GH and median IGF-1. No significant differences in terms of the prevalence of diabetes and prediabetes were found. The glucose peak was achieved earlier in the group that reached GH suppression. The median of the highest glucose values of both subgroups was not different. A correlation between peak and baseline glucose value was found only among those in whom GH suppression was reached. Among these, the median glucose peak (P50) was 177 mg/dl, whereas the 75(th) percentile (P75) and 25(th) percentile (P25) were 199 mg/dl and 120 mg/dl, respectively. Conclusion Considering that 75% of those in whom GH suppression was observed after an oral glucose overload test reached blood glucose values above 120 mg/dl, we propose to use this value as the blood glucose threshold for inducing GH suppression. In light of our results, whenever GH suppression is not observed; and the highest glycemic value is below 120 mg/dl, it might be useful to repeat the test prior to any conclusion. Cureus 2023-01-31 /pmc/articles/PMC9980919/ /pubmed/36874742 http://dx.doi.org/10.7759/cureus.34463 Text en Copyright © 2023, Bugalho et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Bugalho, Maria João
Lopes-Pinto, Mariana
Lemos, Carlos
Nobre, Ema
In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title_full In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title_fullStr In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title_full_unstemmed In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title_short In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
title_sort in search of the hyperglycemic threshold required to induce growth hormone (gh) suppression
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980919/
https://www.ncbi.nlm.nih.gov/pubmed/36874742
http://dx.doi.org/10.7759/cureus.34463
work_keys_str_mv AT bugalhomariajoao insearchofthehyperglycemicthresholdrequiredtoinducegrowthhormoneghsuppression
AT lopespintomariana insearchofthehyperglycemicthresholdrequiredtoinducegrowthhormoneghsuppression
AT lemoscarlos insearchofthehyperglycemicthresholdrequiredtoinducegrowthhormoneghsuppression
AT nobreema insearchofthehyperglycemicthresholdrequiredtoinducegrowthhormoneghsuppression